Brief: Tenax Therapeutics Announces European Patent Office Intention To Grant Patent Covering Use Of Levosimendan In Ph-Hfpef
16/09/2025 14:03
Sept 16 (Reuters) - Tenax Therapeutics Inc TENX.O: TENAX THERAPEUTICS ANNOUNCES EUROPEAN PATENT OFFICE INTENTION TO GRANT PATENT COVERING USE OF LEVOSIMENDAN IN PH-HFPEF Source text: ID:nGNX163wmg Further company coverage: TENX.O ((Reuters.Briefs@thomsonreuters.com;))